Edit

Osterman Group

Metabolism-driven immunity

The group starts at EMBL from August 2026.

Publications

Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel

Osterman IA, Wieland M, Maviza TP, Lashkevich KA, Lukianov DA, Komarova ES, Zakalyukina YV, Buschauer R, Shiriaev DI, Leyn SA, Zlamal JE, Biryukov MV, Skvortsov DA, Tashlitsky VN, Polshakov VI, Cheng J, Polikanov YS, Bogdanov AA, Osterman AL, Dmitriev SE, Beckmann R, Dontsova OA, Wilson DN, Sergiev PV.

Nat Chem Biol 2020

doi:10.1038/s41589-020-0578-x.

Edit